April 2016 saw the first guidance from the court in relation to the 2013 Pharmacy Regulations and it involved one of our applications. Whilst the case related to application made under Regulation 18 (“unforeseen benefits”) it did not consider the test under Regulation 18 per se, but instead focussed on the unusual situation where one …